Delayed Nausea and Vomiting Continue to Reduce Patients' Quality of Life After Highly and Moderately Emetogenic Chemotherapy Despite Antiemetic Treatment

Brigitte Bloechl‐Daum, Robert Deuson, Panagiotis Mavros, +2

Journal of Clinical Oncology

What is a clinically meaningful change on the Functional Assessment of Cancer Therapy–Lung (FACT-L) Questionnaire?Results from Eastern Cooperative Oncology Group (ECOG) Study 5592

David Cella, David T. Eton, Diane L. Fairclough, +5

Journal of Clinical Epidemiology

Functional AssessmentMeaningful ChangeOncologyCancer ManagementOutcomes Research +6

Patient perceptions of the side-effects of chemotherapy: the influence of 5HT3 antagonists

M de Boer-Dennert, Ronald de Wit, PIM Schmitz, +4

British Journal of Cancer

OncologyPatient PerceptionsPharmacologyPharmacotherapyMetronomic Chemotherapy +6

Side effects associated with the use of dexamethasone for prophylaxis of delayed emesis after moderately emetogenic chemotherapy

Janette L. Vardy, Kimberly S. Chiew, Jacqueline Galica, +2

British Journal of Cancer

Translational MedicineEmetogenic ChemotherapyOncologyDexamethasone Symptom QuestionnaireDelayed Emesis +10

Ondansetron Compared with High-Dose Metoclopramide in Prophylaxis of Acute and Delayed Cisplatin-Induced Nausea and Vomiting

P.H.M. de Mulder

Annals of Internal Medicine

Clinical research of Olanzapine for prevention of chemotherapy-induced nausea and vomiting

Lijun Tan, Jiangtao Liu, Xiuli Liu, +4

Journal of Experimental & Clinical Cancer Research

Evaluation of risk factors predictive of nausea and vomiting with current standard-of-care antiemetic treatment: analysis of two phase III trials of aprepitant in patients receiving cisplatin-based chemotherapy

Paul J. Hesketh, Matti Aapro, James C. Street, +1

Supportive Care in Cancer

Drug SafetyCisplatin-based ChemotherapyPhase Iii TrialsMedicineSymptomatic Treatment +10

Validation and Psychometric Assessment of a Short Clinical Scale to Measure Chemotherapy-Induced Nausea and Vomiting: The MASCC Antiemesis Tool

Alex Molassiotis, Peter Coventry, Carrie Tompkins Stricker, +5

Journal of Pain and Symptom Management

Chemotherapy-induced NauseaMedicineSymptomatic TreatmentPatient SafetyGastroenterology +8

Variations in the 5-Hydroxytryptamine Type 3B Receptor Gene as Predictors of the Efficacy of Antiemetic Treatment in Cancer Patients

Pierre‐Benoit Tremblay, R. Kaiser, Orhan Sezer, +5

Journal of Clinical Oncology

Imaging substance P receptors (NK1) in the living human brain using positron emission tomography.

Richard Hargreaves

PubMed

Living Human BrainBrain SciencePharmacotherapyExperimental PharmacologySocial Sciences +17